Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 55.16
ILS 4964.71ILS 55.16
ILS 661.62
60 tablet
Free AirMail shipping Hot
ILS 58.84
ILS 3530.41ILS 58.84
ILS 220.48
30 tablet
Free AirMail shipping Hot
ILS 62.51
ILS 1875.44ILS 62.51
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 66.20
ILS 5957.69ILS 66.20
ILS 330.63
60 tablet
Free AirMail shipping Hot
ILS 68.03
ILS 4082.06ILS 68.03
ILS 110.15
30 tablet
Free AirMail shipping Hot
ILS 69.87
ILS 2096.11ILS 69.87
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
ILS 79.07
ILS 7116.17ILS 79.07
ILS 330.63
60 tablet
Free AirMail shipping Hot
ILS 80.91
ILS 4854.38ILS 80.91
ILS 110.15
30 tablet
Free AirMail shipping Hot
ILS 82.74
ILS 2482.26ILS 82.74
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.